Search
Neuraxis Inc
NRXSAdd to Watchlist
7.500USD
+0.190+2.60%
Market hours 09/24, 12:14（ET）
92.85MMarket Cap
LossP/E TTM
Neuraxis Inc (NRXS) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Neuraxis Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
11.000USD0.00%
NRXS Analyst Recommendation Trends
In the current month, NRXS has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NRXS average Analyst price target in the last month is 11.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
NRXS Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, NRXS EPS is projected to reach -0.340 in FY2026Q3, following reported EPS of -0.188 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.21
-0.19
-0.32
-0.34
-0.12
Actual
-0.18
-0.18
-0.19
--
--
Surprise
+16.68%
+6.22%
+41.28%
--
--
FAQs
What is Neuraxis Inc's expected revenue for the next quarter?
Neuraxis Inc's expected revenue is 2.30M.
What is Neuraxis Inc's price target?
Analysts forecast that Neuraxis Inc's price target is USD 11.00, with the highest forecast at USD 13.00 and the lowest forecast at USD 9.00.
How have Neuraxis IncNRXS's recent earnings per share performed?
The market expectation was USD -0.19, while Neuraxis IncNRXS's earnings per share (EPS) for the previous quarter was USD -0.18. EPS for the next quarter is expected at USD -0.34.
What is the analyst rating for Neuraxis Inc?
Based on the ratings of Neuraxis Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.